Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Bacillus ehimensis" patented technology

Primers and method of detecting bacteria

InactiveUS20050176001A1Rapidly and easily detectingEasily and rapidly presence and absenceSugar derivativesMicrobiological testing/measurementBacilliSalmonella
The first primer of the invention is a primer which, when used in PCR under appropriate conditions, serves to detectably amplify 16S rRNA-encoding DNAs of bacteria of the Escherichia, Salmonella and Vibrio genera, but when used in PCR under the same conditions, does not serve to detectably amplify either chloroplast 16S rRNA-encoding DNAs or mitochondrial 16S rRNA-encoding DNAs. The second primer of the invention is a primer which, when used in PCR under appropriate conditions, serves to detectably amplify 16S rRNA-encoding DNAs of Staphylococcus aureus and Bacillus cereus, but when used in PCR under the same conditions, does not serve to detectably amplify either chloroplast 16S rRNA-encoding DNAs or mitochondrial 16S rRNA-encoding DNAs.
Owner:NISSIN YORK

Primer and probe combination and kit for detecting human pathogenic bacteria

The invention relates to the technical field of medical detection, and in particular, relates to a primer and probe combination and a kit for detecting human pathogenic bacteria. The kit comprises theprimer and probe combination for detecting pseudomonas aeruginosa, escherichia coli, klebsiella pneumoniae, staphylococcus epidermidis, staphylococcus aureus, enterococcus faecium, human staphylococcus and acinetobacter baumannii. According to the kit, the primer and probe combination is adopted, multiple digital PCR is combined, the pathogenic bacteria types and the target nucleic acid copy number in the detection range can be rapidly and accurately identified, the detection method has high sensitivity, and positive detection of low-copy nucleic acid fragments of pathogenic bacteria is guaranteed; meanwhile, the variety of the pathogenic bacteria or the change of the copy number of the target nucleic acid fragment in the body of a pathogenic bacteria infected patient can be dynamically monitored, the treatment effect is assisted and evaluated in time, and reference is provided for optimization of a doctor clinical scheme.
Owner:PILOT GENE TECH HANGZHOU CO LTD

Culture collection process

The invention provides a spawn preservation method adopting semisolid low-temperature air-tight culture. A spawn is inoculated in an aseptic semisolid culture medium which is vertically stored at an ambient temperature of between 6 and 8 DEG C after aseptic liquid paraffin is added into the culture medium. The spawn is staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, bacillus subtilis, clostridium orogenes, aspergillus niger or candida albicans. The specific process is as follows: preparing the semisolid culture medium, carrying out sub-package and sterilization, and then culturing for 2 to 3 days, inoculating the spawn into the semisolid culture medium in a mode of stab inoculation after asepsis is ensured, with the number of stab inoculation points parallel with the plane of the culture medium being no less than 3; pouring the aseptic liquid paraffin with a height of 1 to 2 cm into the culture medium which is sealed by a sealing film and is stored in a refrigerator at a temperature of between 6 and 8 DEG C. The method can not only prolong the spawn preservation time but also keep a relatively stable spawn concentration, thereby saving much cost for production and test, reducing the treatment and discharge of rejected material after spawn use, and reducing environmental hazard.
Owner:药大制药有限公司

Multiple PCR detection kit and method for identifying susceptible bacteria species for intracranial post-operation

The invention aims to provide a multiple PCR detection kit and a method for identifying susceptible bacteria species for intracranial post-operation to eliminate endogenous nucleic acid contamination. The detected bacteria species are the following common bacteria: staphylococcus aureus, enterococcus faecalis, streptococcus pneumoniae, escherichia coli, bacillus pyocyaneus, klebsiella pneumoniae and acinetobacter baumannii. Meanwhile, the invention provides the method to eliminate the endogenous nucleic acid contamination in a raw material of a PCR system and exclude a false positive experimental result of a PCR caused by the endogenous nucleic acid contamination. The detecting method using the kit has the advantages of that the operation is simple and fast, the detection cost is lowered, the detection result is accurate, and the false positive result is reduced. A negative control and a positive control are added in the amplification step, so that the judgment of false positive and false negative is effectively improved, and the detection accuracy is higher.
Owner:江苏睿玻生物科技有限公司

Traditional Chinese medicinal composition for treating edema disease of bamboo rat

The invention discloses a traditional Chinese medicinal composition for treating edema disease of a bamboo rat. The traditional Chinese medicinal composition consists of the following raw medicinal materials in parts by weight: 2-4 parts of cordate houttuynia, 2-4 parts of blackberry lily, 2-4 parts of dandelion, 2-4 parts of sculellaria barbata, 2-4 parts of coptis chinensis and 2-4 parts of root of Chinese pulsatilla, and the composition is prepared by mixing or decocting the various traditional Chinese medicinal raw materials after respectively grinding. The traditional Chinese medicinal composition has the functions of clearing away heat and toxic materials, relieving swelling and pain, resisting inflammation, stopping blooding, removing dampness, killing parasites and the like; the composition is good in antibacterial performance, has a relatively good effect on inhibiting or killing escherichia coli and not easy to result in drug resistance, and is capable of enhancing immunity of the bamboo rat, reducing use of biotic, avoiding abuse of the biotic and benefiting for health of the bamboo rat. The traditional Chinese medicinal composition has relatively high curative rate and effective rate on treating edema disease of the bamboo rat, and is stable in effectiveness; the composition is abundant in crude medicine resource, appropriate in proportion and convenient to use and has an obvious treatment effect.
Owner:思南县邵家桥镇腾鸿竹鼠养殖场

Construction and expression purification method of mycobacterium tuberculosis fusion protein LT29 and application of mycobacterium tuberculosis fusion protein LT29

The invention discloses an expression purification method of a mycobacterium tuberculosis fusion protein LT29. An active-period antigen EAST6 of mycobacterium tuberculosis and an incubation-period antigen Rv2626c of the mycobacterium tuberculosis are fused and connected by a flexible peptide fragment so as to construct the fusion protein ESAT6-linker-Rv2626c. The fusion protein is subjected to expression purification in escherichia coli B21 engineering bacteria, and is combined with an adjuvant DP to construct a tuberculosis subunit vaccine. The fusion protein is successfully expressed and purified in escherichia coli; strong specific cellular immunoreaction aiming at the specific antigens (ESAT6 and Rv2626c) of the mycobacterium tuberculosis can be induced to be generated in a mouse body, the generation of long-term memory T cells is promoted, and the fusion protein has strong immunogenicity. According to the invention, the novel fusion protein LT29 without a label is successfully constructed, expressed and purified, the protein fuses the active-period antigen and the incubation-period antigen of tubercle bacillus, antigen-specific cellular immunity and humoral immunity can be induced to be generated, and the novel fusion protein LT29 is expected to become an effective candidate vaccine for preventing and treating tuberculosis.
Owner:LANZHOU UNIVERSITY

Colorectal cancer biomarker as well as screening method and application thereof

The invention relates to a colorectal cancer biomarker as well as a screening method and application thereof, and belongs to the technical field of cancer diagnosis. The colorectal cancer biomarker provided by the invention comprises human intestinal microorganisms and / or fecal human target genes; the intestinal microorganisms of the human body comprise one or more than two of Brawtella, Pseudomonas 9, Fecal bacillus, fusiform, Wehonor coccus, Escherichia coli-Shigella, Mycobacterium, Fusobacterium, Porphyrinium, peptostreptococcus and Bacteroides; the fecal human body target spot gene comprises ADHFE1 and / or SDC2. The biomarker combination disclosed by the invention is high in sensitivity and good in specificity, and has a profound prospect for estimating the risk of colorectal cancer. According to the invention, a data model is established through the biomarker, and the model can be used for evaluating the risk of colorectal cancer.
Owner:广西爱生生命科技有限公司

Microbial limit inspection method for coptis chinensis formula granules

The invention discloses a microbial limit inspection method for coptis chinensis formula granules. The microbial limit inspection method comprises the following steps: S1, respective preparation of bacterial suspensions of staphylococcus aureus, pseudomonas aeruginosa, bacillus subtilis, candida albicans and aspergillus niger; S2, preparation of a test solution: preparing the test solution containing 3% histidine; S3, applicability test on a counting method for the total number of aerobic bacteria; S4, applicability test on a counting method for the total number of molds and saccharomycetes; and S5, applicability test on an Escherichia coli inspection method, wherein the limit detection standard is as follows: in 1 g of a test sample, the total number of aerobic bacteria is less than or equal to 103 cfu, the total number of molds and saccharomycetes is less than or equal to 102 cfu, and Escherichia coli cannot be detected. The method can be used for limit inspection of microorganisms in the coptis chinensis formula granules, and has the advantages of effectively eliminating the antibacterial activity of a sample, simplifying the inspection process, reducing the reagent dosage and efficiently detecting the microorganisms in the coptis chinensis formula granules.
Owner:北京鸿测科技发展有限公司

Application of Chinese medicine composition in preparation of medicament for treating overhigh level of urine cell factor or receptor thereof and Escherichia coli infection

The invention relates to application of a Chinese medicine composition in preparation of a medicament for treating the overhigh level of a urine cell factor or a receptor thereof and Escherichia coli infection. The cell factor or receptor thereof is sIL-2R, IL-6 and IL-8. The Chinese medicine composition is prepared from the following raw materials in percentage by weight: 14-20 percent of cherokee rose root, 6-10 percent of chinaroot greenbrier, 7-10 percent of akebia trifoliata koidz, 3.0-6.5 percent of Japanese climbing fern and 3.2-6.8 percent of centella. The Chinese medicine composition has obvious curative effect on urinary tract infection with overhigh level of urinary sIL-2R, urinary IL-6 and urinary IL-8 and urinary tract infection and lower respiratory tract infection with Escherichia coli as a main pathogenic bacterium.
Owner:GUILIN SANJIN PHARMACEUTICALS CO LTD

Preenrichment liquid culture medium for vibrio vulnificus clinical detection and application of preenrichment liquid culture medium

The invention relates to preenrichment fluid for vibrio vulnificus detection. A nitrogen source, a carbon source, inorganic salt, vitamins and other growth factors are added to the preenrichment fluid according to the biochemical features and culture features of vibrio vulnificus, and the preenrichment fluid has oxidation reduction potential, pH value and osmotic pressure suitable for the growth of the vibrio vulnificus. Compared with the alkaline peptone water widely used clinically and in food detection, the preenrichment fluid can facilitate the growth and resuscitation of the vibrio vulnificus in to-be-detected samples, can shorten culture time and increase positive detection rate, and can effectively inhibit growth and reproduction of other non-objected bacteria such as escherichia coli, pseudomonas and other gram positive bacteria. The preenrichment fluid is convenient to prepare, low in cost, high in enrichment ability and applicable to vibrio vulnificus detection of various levels of hospitals and detecting institutions.
Owner:THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products